Cathie Wood’s ARK ETFs Sell AMD and Palantir, Buy Deere and Pacific Biosciences

TLDR

• Cathie Wood’s ARK ETFs sold 476,280 shares of Iridium Communications worth $8.06 million, marking the third sale this week
• ARK trimmed positions in tech stocks Palantir ($3.97 million) and AMD ($3.61 million) after recent price rallies
• ARK purchased 12,535 shares of Deere & Co. valued at $5.94 million across ARKQ and ARKX ETFs
• ARK added 633,420 shares of Pacific Biosciences worth $1.27 million through ARKK ETF
• Other purchases included Intellia Therapeutics ($863,256), DoorDash ($544,092), and Honeywell ($553,514)

Cathie Wood’s ARK Invest disclosed its portfolio moves for October 30, 2025, showing a shift away from major technology stocks. The trades included sales of semiconductor and data analytics companies while adding positions in industrial and biotechnology firms.

The largest transaction involved Iridium Communications. ARK Innovation ETF sold 476,280 shares worth $8.06 million. This marked the third time this week ARK reduced its position in the satellite communications company.

Iridium Communications Inc., IRDM

ARK Space Exploration & Innovation ETF sold 19,954 shares of Palantir Technologies valued at $3.97 million. Palantir’s stock has gained recently due to strong demand for government contracts. The sale suggests ARK is taking profits after the stock’s climb.

The ARK Autonomous Technology & Robotics ETF offloaded 13,651 shares of Advanced Micro Devices worth $3.61 million. This followed a similar AMD sale the previous week. The move appears to capitalize on gains after chip stocks rallied.

Industrial and Biotech Purchases

ARK made its biggest purchase in Deere & Co., acquiring 12,535 shares across ARKQ and ARKX ETFs. The transaction totaled $5.94 million. Deere manufactures agricultural and construction equipment with increasing automation and AI features.

Deere & Company, DE

Pacific Biosciences received continued support from ARK. The firm bought 633,420 shares through ARKK ETF worth $1.27 million. Pacific Biosciences specializes in gene sequencing technology for medical applications.

ARK invest purchased 65,797 shares of Intellia Therapeutics across ARKK and ARKG ETFs for $863,256. The biotech company focuses on gene editing treatments. This adds to ARK’s recent biotech investments.

Additional Portfolio Moves

ARK bought 1,196 shares of Synopsys through ARKX ETF valued at $544,586. Synopsys provides electronic design automation software for chip manufacturers.

DoorDash received $544,092 in investment through ARKX ETF with 2,045 shares purchased. The food delivery platform has expanded its services beyond restaurant deliveries.

ARK added 2,600 shares of Honeywell International worth $553,514. Honeywell produces aerospace systems, building technologies, and industrial automation equipment.

The trades show ARK reducing exposure to companies that experienced recent price increases. The tech stock sales included firms in semiconductors, data analytics, and satellite communications. ARK appears to be redistributing capital into industrial automation and genomics sectors.

The Deere purchase aligns with ARK’s focus on companies using artificial intelligence and automation. Farming equipment increasingly incorporates sensors, GPS technology, and machine learning for precision agriculture.

The Pacific Biosciences purchases reflect ongoing interest in gene sequencing technology. ARK has bought shares of the company consistently over multiple trading sessions. The company’s long-read sequencing technology differs from traditional short-read methods.

The week’s trading activity demonstrates Wood’s portfolio management approach of trimming winning positions. The sales of AMD, Palantir, and Iridium came after price appreciation in those stocks. The purchases in Deere and Pacific Biosciences represent additions to existing positions rather than new holdings.

The post Cathie Wood’s ARK ETFs Sell AMD and Palantir, Buy Deere and Pacific Biosciences appeared first on CoinCentral.